# Pilgrims Pride Corp: financial statements, quarterly

PPC · Nasdaq · CIK 802481 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 27

Pages: [Overview](/companies/ppc.md) · [Financials](/companies/ppc/financials.md) · [Filings](/companies/ppc/filings.md) · [Insiders](/companies/ppc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ppc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,528 d](/filings/0000802481-26-000011.md) | [4,362](/filings/0000802481-25-000062.md) | [4,559](/filings/0000802481-25-000110.md) | [4,585](/filings/0000802481-25-000143.md) | [4,372 d](/filings/0000802481-26-000011.md) | [4,463](/filings/0000802481-26-000030.md) | [4,757](/filings/0000802481-26-000051.md) | [4,759](/filings/0000802481-26-000081.md) | [4,518 d](/filings/0000802481-26-000011.md) | [4,533](/filings/0000802481-26-000030.md) | [4,626](/filings/0000802481-26-000051.md) | [4,653](/filings/0000802481-26-000081.md) |
| Cost of revenue | $m | [4,207 d](/filings/0000802481-26-000011.md) | [3,978](/filings/0000802481-25-000062.md) | [3,868](/filings/0000802481-25-000110.md) | [3,901](/filings/0000802481-25-000143.md) | [3,819 d](/filings/0000802481-26-000011.md) | [3,908](/filings/0000802481-26-000030.md) | [4,042](/filings/0000802481-26-000051.md) | [4,100](/filings/0000802481-26-000081.md) | [4,089 d](/filings/0000802481-26-000011.md) | [4,187](/filings/0000802481-26-000030.md) | [4,286](/filings/0000802481-26-000051.md) | [4,320](/filings/0000802481-26-000081.md) |
| Gross profit | $m | [321 d](/filings/0000802481-26-000011.md) | [384](/filings/0000802481-25-000062.md) | [692](/filings/0000802481-25-000110.md) | [684](/filings/0000802481-25-000143.md) | [553 d](/filings/0000802481-26-000011.md) | [555](/filings/0000802481-26-000030.md) | [715](/filings/0000802481-26-000051.md) | [659](/filings/0000802481-26-000081.md) | [429 d](/filings/0000802481-26-000011.md) | [345](/filings/0000802481-26-000030.md) | [340](/filings/0000802481-26-000051.md) | [334](/filings/0000802481-26-000081.md) |
| Selling, general and administrative | $m | [131 d](/filings/0000802481-26-000011.md) | [119](/filings/0000802481-25-000062.md) | [214](/filings/0000802481-25-000110.md) | [145](/filings/0000802481-25-000143.md) | [235 d](/filings/0000802481-26-000011.md) | [134](/filings/0000802481-26-000030.md) | [199](/filings/0000802481-26-000051.md) | [165](/filings/0000802481-26-000081.md) | [215 d](/filings/0000802481-26-000011.md) | [180](/filings/0000802481-26-000030.md) | [265](/filings/0000802481-26-000051.md) | [142](/filings/0000802481-26-000081.md) |
| Operating income | $m | [184 d](/filings/0000802481-26-000011.md) | [250](/filings/0000802481-25-000062.md) | [441](/filings/0000802481-25-000110.md) | [508](/filings/0000802481-25-000143.md) | [307 d](/filings/0000802481-26-000011.md) | [404](/filings/0000802481-26-000030.md) | [512](/filings/0000802481-26-000051.md) | [493](/filings/0000802481-26-000081.md) | [204 d](/filings/0000802481-26-000011.md) | [163](/filings/0000802481-26-000030.md) | [66.0](/filings/0000802481-26-000051.md) | [192](/filings/0000802481-26-000081.md) |
| Interest expense | $m | [66.8 d](/filings/0000802481-26-000011.md) | [41.2](/filings/0000802481-25-000062.md) | [31.2](/filings/0000802481-25-000110.md) | [41.6](/filings/0000802481-25-000143.md) | [47.1 d](/filings/0000802481-26-000011.md) | [41.7](/filings/0000802481-26-000030.md) | [42.5](/filings/0000802481-26-000051.md) | [38.2](/filings/0000802481-26-000081.md) | [39.0 d](/filings/0000802481-26-000011.md) | [37.8](/filings/0000802481-26-000030.md) | [49.9](/filings/0000802481-26-000051.md) | [31.8](/filings/0000802481-26-000081.md) |
| Income tax | $m | [22.4 d](/filings/0000802481-26-000011.md) | [52.1](/filings/0000802481-25-000062.md) | [101](/filings/0000802481-25-000110.md) | [132](/filings/0000802481-25-000143.md) | [40.7 d](/filings/0000802481-26-000011.md) | [94.1](/filings/0000802481-26-000030.md) | [120](/filings/0000802481-26-000051.md) | [118](/filings/0000802481-26-000081.md) | [86.8 d](/filings/0000802481-26-000011.md) | [30.4](/filings/0000802481-26-000030.md) | [8.6](/filings/0000802481-26-000051.md) | [44.0](/filings/0000802481-26-000081.md) |
| Net income | $m | [135 d](/filings/0000802481-26-000011.md) | [174](/filings/0000802481-25-000062.md) | [326](/filings/0000802481-25-000110.md) | [350](/filings/0000802481-25-000143.md) | [236 d](/filings/0000802481-26-000011.md) | [296](/filings/0000802481-26-000030.md) | [356](/filings/0000802481-26-000051.md) | [343](/filings/0000802481-26-000081.md) | [88.0 d](/filings/0000802481-26-000011.md) | [101](/filings/0000802481-26-000030.md) | [13.4](/filings/0000802481-26-000051.md) | [118](/filings/0000802481-26-000081.md) |
| Diluted EPS | $ per share | not reported | [0.73](/filings/0000802481-25-000062.md) | [1.37](/filings/0000802481-25-000110.md) | [1.47](/filings/0000802481-25-000143.md) | not reported | [1.24](/filings/0000802481-26-000030.md) | [1.49](/filings/0000802481-26-000051.md) | [1.44](/filings/0000802481-26-000081.md) | not reported | [0.43](/filings/0000802481-26-000030.md) | [0.06](/filings/0000802481-26-000051.md) | [0.49](/filings/0000802481-26-000081.md) |
| Basic EPS | $ per share | not reported | [0.74](/filings/0000802481-25-000062.md) | [1.38](/filings/0000802481-25-000110.md) | [1.48](/filings/0000802481-25-000143.md) | not reported | [1.25](/filings/0000802481-26-000030.md) | [1.50](/filings/0000802481-26-000051.md) | [1.44](/filings/0000802481-26-000081.md) | not reported | [0.43](/filings/0000802481-26-000030.md) | [0.06](/filings/0000802481-26-000051.md) | [0.49](/filings/0000802481-26-000081.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.7](/filings/0000802481-25-000011.md) | [0.9](/filings/0000802481-24-000036.md) | [1.3](/filings/0000802481-24-000066.md) | [1.9](/filings/0000802481-24-000094.md) | [2.0](/filings/0000802481-26-000011.md) | [2.1](/filings/0000802481-25-000062.md) | [0.8](/filings/0000802481-25-000110.md) | [0.6](/filings/0000802481-25-000143.md) | [0.6](/filings/0000802481-26-000081.md) | [0.5](/filings/0000802481-26-000030.md) | [0.4](/filings/0000802481-26-000051.md) | [0.9](/filings/0000802481-26-000081.md) |
| Current assets | $bn | [4.2](/filings/0000802481-25-000011.md) | [4.2](/filings/0000802481-24-000036.md) | [4.5](/filings/0000802481-24-000066.md) | [5.1](/filings/0000802481-24-000094.md) | [5.1](/filings/0000802481-26-000011.md) | [5.4](/filings/0000802481-25-000062.md) | [4.3](/filings/0000802481-25-000110.md) | [4.1](/filings/0000802481-25-000143.md) | [4.2](/filings/0000802481-26-000081.md) | [4.0](/filings/0000802481-26-000030.md) | [3.7](/filings/0000802481-26-000051.md) | [4.5](/filings/0000802481-26-000081.md) |
| Total assets | $bn | [9.8](/filings/0000802481-25-000011.md) | [9.8](/filings/0000802481-24-000036.md) | [10.1](/filings/0000802481-24-000066.md) | [10.7](/filings/0000802481-24-000094.md) | [10.7](/filings/0000802481-26-000011.md) | [11.0](/filings/0000802481-25-000062.md) | [10.1](/filings/0000802481-25-000110.md) | [10.0](/filings/0000802481-25-000143.md) | [10.3](/filings/0000802481-26-000081.md) | [10.2](/filings/0000802481-26-000030.md) | [10.0](/filings/0000802481-26-000051.md) | [10.9](/filings/0000802481-26-000081.md) |
| Current liabilities | $bn | [2.5](/filings/0000802481-25-000011.md) | [2.3](/filings/0000802481-24-000036.md) | [2.5](/filings/0000802481-24-000066.md) | [2.6](/filings/0000802481-24-000094.md) | [2.6](/filings/0000802481-26-000011.md) | [4.0](/filings/0000802481-25-000062.md) | [2.6](/filings/0000802481-25-000110.md) | [2.7](/filings/0000802481-25-000143.md) | [2.9](/filings/0000802481-26-000081.md) | [2.7](/filings/0000802481-26-000030.md) | [2.7](/filings/0000802481-26-000051.md) | [2.9](/filings/0000802481-26-000081.md) |
| Total liabilities | $bn | [6.5](/filings/0000802481-25-000011.md) | [6.3](/filings/0000802481-24-000036.md) | [6.3](/filings/0000802481-24-000066.md) | [6.5](/filings/0000802481-24-000094.md) | [6.4](/filings/0000802481-26-000011.md) | [7.8](/filings/0000802481-25-000062.md) | [6.4](/filings/0000802481-25-000110.md) | [6.4](/filings/0000802481-25-000143.md) | [6.6](/filings/0000802481-26-000081.md) | [6.5](/filings/0000802481-26-000030.md) | [6.3](/filings/0000802481-26-000051.md) | [7.0](/filings/0000802481-26-000081.md) |
| Long-term debt | $bn | [3.3](/filings/0000802481-25-000011.md) | not reported | not reported | not reported | [3.2](/filings/0000802481-25-000011.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.0](/filings/0000802481-25-000011.md) | [0.0](/filings/0000802481-24-000036.md) | [0.0](/filings/0000802481-24-000066.md) | [0.0](/filings/0000802481-24-000094.md) | [0.0](/filings/0000802481-26-000011.md) | [0.0](/filings/0000802481-25-000062.md) | [0.0](/filings/0000802481-25-000110.md) | [0.0](/filings/0000802481-25-000143.md) | [0.0](/filings/0000802481-26-000081.md) | [0.0](/filings/0000802481-26-000030.md) | [0.0](/filings/0000802481-26-000051.md) | [0.0](/filings/0000802481-26-000081.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [3.3](/filings/0000802481-25-000011.md) | [3.5](/filings/0000802481-24-000036.md) | [3.7](/filings/0000802481-24-000066.md) | [4.2](/filings/0000802481-24-000094.md) | [4.2](/filings/0000802481-26-000011.md) | [3.1](/filings/0000802481-25-000062.md) | [3.7](/filings/0000802481-25-000110.md) | [3.5](/filings/0000802481-25-000143.md) | [3.7](/filings/0000802481-26-000081.md) | [3.7](/filings/0000802481-26-000030.md) | [3.7](/filings/0000802481-26-000051.md) | [3.9](/filings/0000802481-26-000081.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [278 d](/filings/0000802481-26-000011.md) | [271](/filings/0000802481-25-000062.md) | [719 d](/filings/0000802481-25-000110.md) | [651 d](/filings/0000802481-25-000143.md) | [349 d](/filings/0000802481-26-000011.md) | [127](/filings/0000802481-26-000030.md) | [495 d](/filings/0000802481-26-000051.md) | [458 d](/filings/0000802481-26-000081.md) | [291 d](/filings/0000802481-26-000011.md) | [141](/filings/0000802481-26-000030.md) | [331 d](/filings/0000802481-26-000051.md) | [212 d](/filings/0000802481-26-000081.md) |
| Capital expenditure | $m | [126 d](/filings/0000802481-25-000011.md) | [99.1](/filings/0000802481-25-000062.md) | [101 d](/filings/0000802481-25-000110.md) | [85.8 d](/filings/0000802481-25-000143.md) | [173 d](/filings/0000802481-26-000011.md) | [98.8](/filings/0000802481-26-000030.md) | [156 d](/filings/0000802481-25-000110.md) | [182 d](/filings/0000802481-26-000081.md) | [(182) d](/filings/0000802481-26-000051.md) | [236](/filings/0000802481-26-000030.md) | [254 d](/filings/0000802481-26-000051.md) | [201 d](/filings/0000802481-26-000081.md) |
| Dividends paid | $m | not reported | not reported | not reported | [0.0 d](/filings/0000802481-25-000143.md) | [0.0 d](/filings/0000802481-26-000011.md) | not reported | not reported | [499 d](/filings/0000802481-26-000081.md) | [0.0 d](/filings/0000802481-26-000011.md) | not reported | not reported | [0.0 d](/filings/0000802481-26-000081.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-26) | Q2 FY2023 (2023-06-25) | Q3 FY2023 (2023-09-24) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [237](/filings/0000802481-24-000036.md) | [237](/filings/0000802481-24-000066.md) | [237](/filings/0000802481-24-000094.md) | [237](/filings/0000802481-25-000062.md) | [238](/filings/0000802481-25-000110.md) | [238](/filings/0000802481-25-000143.md) | [238](/filings/0000802481-26-000030.md) | [238](/filings/0000802481-26-000051.md) | [239](/filings/0000802481-26-000081.md) | [239](/filings/0000802481-26-000030.md) | [239](/filings/0000802481-26-000051.md) | [239](/filings/0000802481-26-000081.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 238,112,010 at 2026-09-27, from the cover of the [10-Q filed 2026-10-29](/filings/0000802481-26-000081.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 06:16 ET. No prices; not investment advice.